How AEDs in Public Places Can Restart Hearts | FDA News
Image Español Sudden cardiac arrest occurs when the heart suddenly and unexpectedly stops pumping blood. It can happen to anyone, at any time, and signs include sudden collapse and immediate…
.jpg "FDA-Approved Devices That Help Keep the Heart Beating | FDA News")
FDA-Approved Devices That Help Keep the Heart Beating | FDA News
Image Español Heart disease, also called cardiovascular disease, can have serious consequences. It’s the leading cause of death for men and women in the United States. Medical devices approved by…
Tattoo Removal: Options and Results | FDA News
That tattoo on your arm of a former flame—the one that seemed like a great idea years ago—is kind of embarrassing today. And your spouse is not too crazy about…
‘All Natural’ Alternatives for Erectile Dysfunction: A Risky Proposition | FDA News
Image Español Men, beware! Products falsely marketed as “dietary supplements” or “foods” that promise to enhance your sexual performance or increase sexual stimulation might contain hidden drug ingredients or other…
Detección de cáncer de mama: el termograma no sustituye a la mamografía | FDA News
Image CaptionLa mamografía (L) son unos rayos X del seno que puede identificar tipos de tejido con diferentes densidades, como masas. La termografía (R) produce una imagen infrarroja con patrones…
No Bones (or Bone Treats) About It: Reasons Not to Give Your Dog Bones | FDA News
Español NOTE: FDA initially published this Consumer Update in 2015, and has had information on this topic on its website since 2010. The agency regularly updates the number of reports…
For Women: The FDA Gives Tips to Prevent Heart Disease | FDA News
Image Español More women die from heart disease than from any other cause: about one in five American women, according to the Centers for Disease Control and Prevention. But you…
FDA Approves New Treatment For Adults With Relapsed Or Refractory Large-B-Cell Lymphoma | FDA News
For Immediate Release: February 05, 2021 Today, the U.S. Food and Drug Administration approved Breyanzi (lisocabtagene maraleucel), a cell-based gene therapy to treat adult patients with certain types of large…